PT Pyridam Farma Tbk (IDX: PYFA)
Indonesia
· Delayed Price · Currency is IDR 126.00
+4.00 (3.28%)
Sep 10, 2024, 10:18 AM WIB
PT Pyridam Farma Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 702,068 | 702,068 | 715,425 | 630,530 | 277,398 | 247,115 | Upgrade
|
| Revenue Growth (YoY) | -1.87% | -1.87% | 13.46% | 127.30% | 12.25% | -1.33% | Upgrade
|
| Cost of Revenue | 406,752 | 406,752 | 464,580 | 385,949 | 113,508 | 106,912 | Upgrade
|
| Gross Profit | 295,316 | 295,316 | 250,845 | 244,581 | 163,890 | 140,203 | Upgrade
|
| Selling, General & Admin | 303,147 | 303,147 | 286,433 | 219,977 | 134,340 | 129,282 | Upgrade
|
| Other Operating Expenses | -9,589 | -9,589 | -25,604 | -26,508 | -1,850 | -3,153 | Upgrade
|
| Operating Expenses | 293,558 | 293,558 | 260,829 | 193,468 | 132,490 | 126,129 | Upgrade
|
| Operating Income | 1,758 | 1,758 | -9,985 | 51,113 | 31,401 | 14,073 | Upgrade
|
| Interest Expense | -85,886 | -85,886 | -86,911 | -41,927 | -2,146 | -2,529 | Upgrade
|
| Interest & Investment Income | 1,372 | 1,372 | 4,309 | 299.17 | 63.38 | 23.25 | Upgrade
|
| Currency Exchange Gain (Loss) | 78.47 | 78.47 | -278.68 | 160.29 | 189.25 | 157.91 | Upgrade
|
| Other Non Operating Income (Expenses) | -613.64 | -613.64 | -174.99 | -1,456 | -419.01 | -257.03 | Upgrade
|
| EBT Excluding Unusual Items | -83,291 | -83,291 | -93,040 | 8,189 | 29,089 | 11,469 | Upgrade
|
| Gain (Loss) on Sale of Assets | 43.5 | 43.5 | 6,296 | 622.44 | 553.68 | 1,050 | Upgrade
|
| Other Unusual Items | - | - | 349,824 | - | - | - | Upgrade
|
| Pretax Income | -83,248 | -83,248 | 263,080 | 8,811 | 29,642 | 12,519 | Upgrade
|
| Income Tax Expense | 1,979 | 1,979 | -12,392 | 3,332 | 7,538 | 3,176 | Upgrade
|
| Earnings From Continuing Operations | -85,226 | -85,226 | 275,472 | 5,479 | 22,104 | 9,343 | Upgrade
|
| Minority Interest in Earnings | 5.5 | 5.5 | -230.7 | - | - | - | Upgrade
|
| Net Income | -85,221 | -85,221 | 275,241 | 5,479 | 22,104 | 9,343 | Upgrade
|
| Net Income to Common | -85,221 | -85,221 | 275,241 | 5,479 | 22,104 | 9,343 | Upgrade
|
| Net Income Growth | - | - | 4923.61% | -75.21% | 136.59% | 10.60% | Upgrade
|
| Shares Outstanding (Basic) | 535 | 535 | 535 | 535 | 535 | 535 | Upgrade
|
| Shares Outstanding (Diluted) | 535 | 535 | 535 | 535 | 535 | 535 | Upgrade
|
| EPS (Basic) | -159.27 | -159.27 | 514.39 | 10.24 | 41.31 | 17.46 | Upgrade
|
| EPS (Diluted) | -159.27 | -159.27 | 514.39 | 10.24 | 41.31 | 17.46 | Upgrade
|
| EPS Growth | - | - | 4923.61% | -75.21% | 136.59% | 10.60% | Upgrade
|
| Free Cash Flow | -117,347 | -117,347 | -31,832 | -179,149 | -6,583 | 14,216 | Upgrade
|
| Free Cash Flow Per Share | -219.31 | -219.31 | -59.49 | -334.81 | -12.30 | 26.57 | Upgrade
|
| Gross Margin | 42.06% | 42.06% | 35.06% | 38.79% | 59.08% | 56.74% | Upgrade
|
| Operating Margin | 0.25% | 0.25% | -1.40% | 8.11% | 11.32% | 5.70% | Upgrade
|
| Profit Margin | -12.14% | -12.14% | 38.47% | 0.87% | 7.97% | 3.78% | Upgrade
|
| Free Cash Flow Margin | -16.71% | -16.71% | -4.45% | -28.41% | -2.37% | 5.75% | Upgrade
|
| EBITDA | 53,948 | 53,948 | 55,363 | 77,872 | 39,137 | 21,495 | Upgrade
|
| EBITDA Margin | 7.68% | 7.68% | 7.74% | 12.35% | 14.11% | 8.70% | Upgrade
|
| D&A For EBITDA | 52,190 | 52,190 | 65,348 | 26,759 | 7,736 | 7,421 | Upgrade
|
| EBIT | 1,758 | 1,758 | -9,985 | 51,113 | 31,401 | 14,073 | Upgrade
|
| EBIT Margin | 0.25% | 0.25% | -1.40% | 8.11% | 11.32% | 5.70% | Upgrade
|
| Effective Tax Rate | - | - | - | 37.82% | 25.43% | 25.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.